Updates sent to Twitter, March 22-28

Updates about CSC sent to Twitter during the fourth week of March:

Understanding the cancer stem cell hypothesis, Portal (OICR Newsletter) Winter 2009 [March 27]: http://tinyurl.com/ckcdab
[Full text is publicly accessible].

Stem-cell driven cancer: "Hands-off" regulation of cancer development [OA][March 26]: http://www.ncbi.nlm.nih.gov/pubmed/19279406
[Full text is openly accessible].

MicroRNA-199b-5p Impairs Cancer Stem Cells through Negative Regulation of HES1 in Medulloblastoma [OA][March 26]: http://tinyurl.com/ccgt8y
[Full text is openly accessible].

Making Connections between Stem Cells and Cancer, NCI Director's Update, Mar. 24, 2009 [March 25]: http://www.cancer.gov/ncicancerbulletin/032409/page4
[Full text is publicly accessible].

Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits [March 25]: http://dx.doi.org/10.1038/nrc2620
[Full text is publicly accessible (free registration is required)].

Nuclear signalling by tumour-associated antigen EpCAM (reference 1 in Micromet news item [see below]) [March 24]: http://www.ncbi.nlm.nih.gov/pubmed/19136966

Micromet Has Started a New Phase 2 Trial with Adecatumumab in Colorectal Cancer Patients [March 24]: http://tinyurl.com/d9oc9j
[Full text is publicly accessible].

Oncolytic reovirus effectively targets breast cancer stem cells, Mol Ther 2009(Mar 17) [March 23]: http://www.ncbi.nlm.nih.gov/pubmed/19293772

Pancreatic cancer stem cells and relevance to cancer treatments, J Cell Biochem 2009(Mar 19) [March 23]: http://www.ncbi.nlm.nih.gov/pubmed/19301275